Biogen signals beyond the news: 43+ signals from 5 sources
The latest Biogen signal on this page is from Oct 27, 2026 (Patents): "BIOGEN MA INC.'s patent output is accelerating: 19 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), YouTube (11) and LinkedIn (9).
Public (BIIB)Biotechnology Research10,000+ employeesbiogen.comLinkedIn
Get Biogen's live signals in Claude or ChatGPT, or by API
What changed at Biogen this week? Use Autobound signals for biogen.com.- Signals
- 43+
- Sources
- 5
- Last 90 days
- 17
- Latest
- Oct 27, 2026
Source: Autobound Signal API · 76 signals tracked for Biogen · updated
Other signals · latest 10
Latest Biogen signals by source
43+ signals for Biogen across 5 sources.
Patents · Patent pace
BIOGEN MA INC.'s patent output is accelerating: 19 grants in the past year, 2 in the past 30 days.
Over the past year BIOGEN MA INC. received 19 US patent grants; the recent pace (5 in 90 days) is accelerating versus its trailing baseline.
- Grants, 12 months
- 19
- Grants, 90 days
- 5
- Grants, 30 days
- 2
- Pace
- Accelerating
Patents · Patent grant
Biogen was granted a patent for combination treatments for multiple sclerosis.
In October 2026 Biogen patented a drug combination for treating multiple sclerosis and other autoimmune diseases in clinical care.
- Patent title
- Combination treatment methods of multiple sclerosis
- Grant date
- Oct 13, 2026
- Inventors
- Michael Joseph Palte, Brian T. Hopkins, Matthew P. Scaramozza, Michael Christian Mingueneau
Glassdoor · Financial stability praise
Company has exciting future in new disease areas
An Alliance Director noted the company has entered many new interesting disease areas.
- Overall rating
- 3.7 of 5
- CEO approval
- 59%
- Reviews read
- 3
- Review window
- Sep 18, 2026 to Oct 8, 2026
Glassdoor · Consistent leadership complaints
Mid-management performance is chaotic and needs improvement
One Director review specifically mentioned chaotic mid-management as an area for improvement, despite overall positive ratings for work-life balance and senior leadership.
- Overall rating
- 3.7 of 5
- CEO approval
- 59%
- Reviews read
- 3
- Review window
- Sep 18, 2026 to Oct 8, 2026
Patents · Patent grant
Biogen was granted a patent for compounds that degrade BTK.
In September 2026 Biogen patented drug candidates designed to remove Bruton's tyrosine kinase in cells, for potential use in targeted pharmaceutical treatments.
- Patent title
- Compounds for targeting degradation of Bruton's tyrosine kinase
- Grant date
- Sep 29, 2026
- Inventors
- Kevin M. Guckian, Eric Stefan, Corey Don Anderson, Jae Young Ahn
Reddit · Pricing change
Biogen submitted a substantially improved financial offer and lowered pricing terms for Skyclarys, securing reimbursement approval from Ireland's Health Service Executive (HSE).
Post: "HSE approves Skyclarys reimbursement for Friedreich's ataxia patients"
- Subreddit
- r/ireland
- Upvotes
- 181
- Comments
- 105
- Sentiment
- Positive
YouTube
For Sneezing Watery Eyes and Fever Biogen no 14 Dr Masood Homoeopathic Pharma product#shorts
Biogen presents a homoeopathic product for sneezing, watery eyes, and fever.
- Channel
- Dr. Tania official
- Views
- 10
- Comments
- 0
- Tags
- Product Information, Homoeopathic Medicine
YouTube
Apellis Q1 Preview: Biogen Deal Closing Soon
Apellis preview focuses on Q1 earnings and potential closing of the Biogen acquisition.
- Channel
- Fazen Markets
- Views
- 0
- Comments
- 0
- Tags
- Acquisition, Earnings Report, Healthcare
LinkedIn
Biogen scientists aim to transform patient lives through groundbreaking science in neurology, immunology, and rare diseases.
Every day, our scientists pursue a simple but powerful mission: to help transform the lives of patients through groundbreaking science. Our teams work across a broad spectrum of disease areas in neurology, immunology, and rare disease. Learn more about our Research and Development organizations and how we’re making...
- Likes
- 94
- Comments
- 3
- Tags
- Product Development, Medical Research, Research & Development
- Initiatives
- advancing scientific research and development
LinkedIn
Biogen thanks attendees and discusses motor neuron protection at the 5th SMA Scientific Congress.
As the 5th International Scientific Congress on spinal muscular atrophy (SMA) draws to a close tomorrow, we would like to thank the healthcare professionals, partners and the patient community who connected with us. This year, discussions focused on motor neuron protection and its potential role in informing...
- Likes
- 176
- Comments
- 3
- Tags
- Medical Research
Showing 10 of 43+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Biogen with the Signal API
One POST /v1/companies/enrich call with biogen.com returns Biogen signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "biogen.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Other signals at related companies
Questions about Biogen other signals
What signals does Autobound track for Biogen besides news and filings?
What are people saying about Biogen online?
What do employees say about working at Biogen?
Has Biogen been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .